Two Sigma Advisers’s Corcept Therapeutics CORT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.55M Sell
130,100
-176,700
-58% -$13M 0.02% 517
2025
Q1
$35M Sell
306,800
-75,000
-20% -$8.57M 0.08% 228
2024
Q4
$19.2M Sell
381,800
-75,300
-16% -$3.79M 0.04% 330
2024
Q3
$21.2M Sell
457,100
-57,900
-11% -$2.68M 0.05% 311
2024
Q2
$16.7M Sell
515,000
-245,200
-32% -$7.97M 0.04% 389
2024
Q1
$19.1M Buy
760,200
+223,800
+42% +$5.64M 0.04% 358
2023
Q4
$17.4M Buy
536,400
+126,700
+31% +$4.12M 0.04% 371
2023
Q3
$11.2M Buy
409,700
+98,100
+31% +$2.67M 0.03% 440
2023
Q2
$6.93M Buy
+311,600
New +$6.93M 0.02% 625
2021
Q1
Sell
-14,700
Closed -$385K 2589
2020
Q4
$385K Sell
14,700
-22,700
-61% -$595K ﹤0.01% 1959
2020
Q3
$651K Sell
37,400
-90,000
-71% -$1.57M ﹤0.01% 1699
2020
Q2
$2.14M Buy
127,400
+91,000
+250% +$1.53M 0.01% 1172
2020
Q1
$433K Buy
+36,400
New +$433K ﹤0.01% 1862
2019
Q4
Sell
-13,200
Closed -$187K 2370
2019
Q3
$187K Buy
13,200
+2,200
+20% +$31.2K ﹤0.01% 2054
2019
Q2
$123K Sell
11,000
-20,303
-65% -$227K ﹤0.01% 2192
2019
Q1
$367K Buy
31,303
+6,000
+24% +$70.3K ﹤0.01% 1916
2018
Q4
$338K Buy
+25,303
New +$338K ﹤0.01% 1929
2018
Q2
Sell
-128,894
Closed -$2.12M 2383
2018
Q1
$2.12M Sell
128,894
-95,300
-43% -$1.57M 0.01% 1220
2017
Q4
$4.05M Sell
224,194
-68,100
-23% -$1.23M 0.01% 928
2017
Q3
$5.64M Buy
292,294
+129,000
+79% +$2.49M 0.02% 755
2017
Q2
$1.93M Sell
163,294
-53,000
-25% -$625K 0.01% 1225
2017
Q1
$2.37M Sell
216,294
-60,006
-22% -$658K 0.01% 1170
2016
Q4
$2.01M Buy
276,300
+120,213
+77% +$873K 0.01% 1176
2016
Q3
$1.02M Buy
156,087
+6,000
+4% +$39K ﹤0.01% 1346
2016
Q2
$819K Sell
150,087
-13,900
-8% -$75.9K ﹤0.01% 1262
2016
Q1
$767K Sell
163,987
-16,191
-9% -$75.7K ﹤0.01% 1256
2015
Q4
$897K Sell
180,178
-13,420
-7% -$66.8K 0.01% 1077
2015
Q3
$766K Buy
193,598
+139,611
+259% +$552K ﹤0.01% 1125
2015
Q2
$324K Buy
+53,987
New +$324K ﹤0.01% 1588